Results 251 to 260 of about 55,098,274 (381)

Development and internal validation of a diagnostic prediction model for life-threatening events in callers with shortness of breath: a cross-sectional study in out-of-hours primary care. [PDF]

Br J Gen Pract
Spek M, Venekamp RP, de Hond AA, de Groot E, Geersing GJ, Dobbe AS, Delissen M, Rutten FH, van Smeden M, Zwart DL.   +9 more
europepmc   +1 more source

A Possibile Symmetry in Sakata's Model for Bosons-Baryons System [PDF]

, 1959
Mineo Ikeda, Shûzô Ogawa, Yoshio Ohnuki   +2 more
openalex   +1 more source

The use of system dynamics group model building for analysing event causality within the nuclear industry [PDF]

, 2010
Carhart, NJ, Yearworth, M
core  

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Development of the treatment prediction model in the artificial intelligence in depression - medication enhancement study. [PDF]

Npj Ment Health Res
Benrimoh D, Armstrong C, Mehltretter J, Fratila R, Perlman K, Israel S, Kapelner A, Parikh SV, Karp JF, Heller K, Turecki G.   +10 more
europepmc   +1 more source

Flocks, herds, and schools: a distributed behavioral model

International Conference on Computer Graphics and Interactive Techniques, 1987
Craig W. Reynolds
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Liquid white box model as an explainable AI for surgery. [PDF]

NPJ Digit Med
Riva-Cambrin HA, Singh R, Lama S, Sutherland GR.   +3 more
europepmc   +1 more source

Phase Transition of Husimi-Temperley Model of Imperfect Gas [PDF]

, 1955
Shigetoshi Katsura
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source